Literature DB >> 16304267

Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus.

Miquel Falguera1, Ricard Pifarre, Antonio Martin, Anas Sheikh, Anna Moreno.   

Abstract

STUDY
OBJECTIVES: It has been suggested that diabetes mellitus is associated with an increased susceptibility to infection, the risk of using more aggressive therapeutic agents, and increased morbidity and mortality; however, current evidence supporting these events in the field of pneumonia is scarce. The aim of the present study was to provide information on clinical and microbiological characteristics and the outcome of community-acquired pneumonia in patients with diabetes mellitus.
DESIGN: Prospective study of cases.
SETTING: A university hospital in Lleida, Spain. PATIENTS: During a 5-year period, we prospectively studied the clinical and radiologic characteristics, the spectrum of causative agents and other microbiological data, and the outcomes of 660 consecutive episodes of community-acquired pneumonia. Data derived from 106 patients with diabetes mellitus were analyzed and compared with data obtained from the remaining population. MEASUREMENTS AND
RESULTS: Patients with diabetes mellitus were significantly older (p = 0.001) and more frequently had other concomitant comorbid conditions (p = 0.018). Diabetes was also significantly associated with the development of pleural effusion (p = 0.015) and mortality (p = 0.002); for both events, diabetes remained as an independent predictive factor in multivariate analyses. By contrast, the incidence of the main etiologic agents, and the bacteremia or empyema rates did not show significant differences in relation to the remaining patients. In the subgroup of patients with diabetes, mortality was associated with the presence of multilobar infiltrates (p = 0.004), concomitant underlying diseases (p = 0.004), and some diabetes-related complications (nephropathy, p = 0.040; and vasculopathy, p = 0.002), although only multilobar infiltrates and comorbidities were selected as prognostic factors in the multivariate analysis.
CONCLUSIONS: In patients with community-acquired pneumonia, diabetes mellitus is associated with a poor prognosis, increasing the rate of pleural effusion and mortality. Our results suggest that this adverse outcome is more attributable to the underlying circumstances of patients than to uncommon microbiological findings.

Entities:  

Mesh:

Year:  2005        PMID: 16304267     DOI: 10.1378/chest.128.5.3233

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  46 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

2.  Identification of bacterial pathogens in pediatric community-acquired lower respiratory tract infection using a simplified procedure of sputum sampling and examination: comparison between hospitalized children with and without underlying diseases.

Authors:  T Hoshina; K Kusuhara; T Takimoto; M Saito; T Hara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-02-24       Impact factor: 3.267

3.  Antibiotic administration longer than eight hours after triage and mortality of community-acquired pneumonia in patients with diabetes mellitus.

Authors:  M S Bader; K A Abouchehade; Y Yi; B Haroon; L D Bishop; J Hawboldt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-02-01       Impact factor: 3.267

4.  Fatty liver is associated with recurrent bacterial infections independent of metabolic syndrome.

Authors:  William Nseir; Hussein Taha; Julnar Khateeb; Maria Grosovski; Nimer Assy
Journal:  Dig Dis Sci       Date:  2011-05-12       Impact factor: 3.199

5.  The influence of pre-existing diabetes mellitus on the host immune response and outcome of pneumonia: analysis of two multicentre cohort studies.

Authors:  Sachin Yende; Tom van der Poll; Minjae Lee; David T Huang; Anne B Newman; Lan Kong; John A Kellum; Tamara B Harris; Doug Bauer; Suzanne Satterfield; Derek C Angus
Journal:  Thorax       Date:  2010-10       Impact factor: 9.139

6.  Insulin-treated diabetes is not associated with increased mortality in critically ill patients.

Authors:  Jean-Louis Vincent; Jean-Charles Preiser; Charles L Sprung; Rui Moreno; Yasser Sakr
Journal:  Crit Care       Date:  2010-02-04       Impact factor: 9.097

7.  Dysglycaemia and 90 day and 1 year risks of death or readmission in patients hospitalised for community-acquired pneumonia.

Authors:  D T Eurich; J M Gamble; T J Marrie; S R Majumdar
Journal:  Diabetologia       Date:  2009-11-20       Impact factor: 10.122

8.  The impact of pre-existing heart failure on pneumonia prognosis: population-based cohort study.

Authors:  Reimar W Thomsen; Nongyao Kasatpibal; Anders Riis; Mette Nørgaard; Henrik T Sørensen
Journal:  J Gen Intern Med       Date:  2008-06-24       Impact factor: 5.128

9.  Benefit of adjunct corticosteroids for community-acquired pneumonia in diabetic patients.

Authors:  Milica Popovic; Claudine A Blum; Nicole Nigro; Beat Mueller; Philipp Schuetz; Mirjam Christ-Crain
Journal:  Diabetologia       Date:  2016-09-10       Impact factor: 10.122

10.  Prediction of complicated lower respiratory tract infections in older patients with diabetes.

Authors:  Leonie M A J Venmans; Jettie Bont; Kees J Gorter; Theo J M Verheij; Guy E H M Rutten; Eelko Hak
Journal:  Br J Gen Pract       Date:  2008-08       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.